Orencia Approved for Use in Psoriatic Arthritis
On July 6 the U.S. Food and Drug Administration (FDA) approved ORENCIA (abatacept) for the treatment of adults with active Psoriatic Arthritis (PsA).…
rheumnow.com
FDA Approves Orencia for Psoriatic Arthritis
FDA Approves Orencia for Psoriatic Arthritis
mdedge.com
FDA approves Orencia for PsA
The FDA has approved Orencia for the treatment of patients with active psoriatic arthritis. It is approved for both subcutaneous and intravenous injections, according to a company press release. “This approval underscores the efficacy of Orencia in adult patients with active psoriatic arthriti…
healio.com